Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

BUY
$4.67 - $6.55 $30,742 - $43,118
6,583 Added 27.42%
30,593 $146,000
Q1 2023

May 08, 2023

BUY
$4.95 - $6.09 $33,333 - $41,010
6,734 Added 38.98%
24,010 $136,000
Q4 2022

Feb 01, 2023

BUY
$5.09 - $9.05 $33,634 - $59,802
6,608 Added 61.94%
17,276 $96,000
Q1 2022

Apr 21, 2022

BUY
$6.3 - $8.84 $23,782 - $33,371
3,775 Added 54.77%
10,668 $76,000
Q2 2021

Jul 30, 2021

SELL
$18.46 - $24.36 $32,434 - $42,800
-1,757 Reduced 20.31%
6,893 $164,000
Q4 2020

Jan 28, 2021

BUY
$23.25 - $37.73 $201,112 - $326,364
8,650 New
8,650 $212,000
Q2 2019

Jul 30, 2019

SELL
$2.28 - $7.35 $2,466 - $7,952
-1,082 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$12.81 - $16.85 $13,860 - $18,231
1,082
1,082 $17,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.